Fig. 3. Changes in waist-to-height ratio by body mass index status. Asterisk (*) represents significant difference (P<0.05) between visit 1 and each visit. Visit 1, at the start of gonadotropin-releasing hormone (GnRH) agonist treatment; visit 2, at 1 year after GnRH agonist treatment; visit 3, at the end of GnRH agonist treatment; visit 4, at 6-12 months after GnRH agonist discontinuation.